4//SEC Filing
Pauls Matthew 4
Accession 0001415889-25-009298
CIK 0001484565other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:24 PM ET
Size
9.4 KB
Accession
0001415889-25-009298
Insider Transaction Report
Form 4
Pauls Matthew
Director
Transactions
- Sale
Common Stock
2025-03-28$71.55/sh−5,937$424,797→ 6,500 total - Exercise/Conversion
Employee stock option (right to buy)
2025-03-28−5,937→ 9,063 totalExercise: $46.31Exp: 2033-08-15→ Common Stock (5,937 underlying) - Exercise/Conversion
Common Stock
2025-03-28$4.60/sh+5,937$27,310→ 12,437 total
Footnotes (3)
- [F1]Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F2]This transaction was executed in multiple trades at prices ranging from $71.54 to $71.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]One forty-eighth (1/48th) of the shares subject to the Option shall vest on September 15, 2023 and each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date.
Documents
Issuer
SOLENO THERAPEUTICS INC
CIK 0001484565
Entity typeother
Related Parties
1- filerCIK 0001573429
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 7:24 PM ET
- Size
- 9.4 KB